Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Isoliquiritigenin (ISL) and its Formulations: Potential Antitumor Agents
Tingting Zhao, Yuqing Xu, Huimin Hu, et al.
Current Medicinal Chemistry (2018) Vol. 26, Iss. 37, pp. 6786-6796
Closed Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

Flavonoids in Cancer Metastasis
Alena Líšková, Lenka Koklesová, Marek Samec, et al.
Cancers (2020) Vol. 12, Iss. 6, pp. 1498-1498
Open Access | Times Cited: 152
Flavonoids against the SARS-CoV-2 induced inflammatory storm
Alena Líšková, Marek Samec, Lenka Koklesová, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 138, pp. 111430-111430
Open Access | Times Cited: 133
Isoliquiritigenin triggers developmental toxicity and oxidative stress–mediated apoptosis in zebrafish embryos/larvae via Nrf2-HO1/JNK-ERK/mitochondrion pathway
Zhenzhen Song, Yun Zhang, Huazheng Zhang, et al.
Chemosphere (2019) Vol. 246, pp. 125727-125727
Closed Access | Times Cited: 83
Isoliquiritigenin inhibits circ0030018 to suppress glioma tumorigenesis via the miR‐1236/HER2 signaling pathway
Aiqun Liu, Baohong Jiang, Cailu Song, et al.
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 37
MicroRNA-mediated autophagy regulation in cancer therapy: The role in chemoresistance/chemosensitivity
Milad Ashrafizadeh, Ali Zarrabi, Sima Orouei, et al.
European Journal of Pharmacology (2020) Vol. 892, pp. 173660-173660
Closed Access | Times Cited: 68
Hispidulin: A promising flavonoid with diverse anti-cancer properties
Kai‐Li Liu, Fei Zhao, Jingjing Yan, et al.
Life Sciences (2020) Vol. 259, pp. 118395-118395
Closed Access | Times Cited: 54
Isoliquiritigenin induces HMOX1 and GPX4-mediated ferroptosis in gallbladder cancer cells
Zeyu Wang, Weijian Li, Xue Wang, et al.
Chinese Medical Journal (2023)
Open Access | Times Cited: 18
Exploring the mechanism of solubilization and release of isoliquiritigenin in deep eutectic solvents
Yi Hu, Peiyi Liang, Zhuxian Wang, et al.
International Journal of Pharmaceutics (2023) Vol. 644, pp. 123298-123298
Closed Access | Times Cited: 17
Recent Advances in Glycyrrhiza glabra (Licorice)-Containing Herbs Alleviating Radiotherapy- and Chemotherapy-Induced Adverse Reactions in Cancer Treatment
Kai-Lee Wang, Yingchun Yu, Hsin-Yuan Chen, et al.
Metabolites (2022) Vol. 12, Iss. 6, pp. 535-535
Open Access | Times Cited: 24
Spectrum‐effect relationship between UPLC fingerprints and anti‐lung cancer effect of Panax ginseng
Xiaowei Zhou, Hai‐Yang Liu, Mingyu Zhang, et al.
Phytochemical Analysis (2020) Vol. 32, Iss. 3, pp. 339-346
Open Access | Times Cited: 33
NLRP3 Inflammasome Pharmacological Inhibitors in Glycyrrhiza for NLRP3-Driven Diseases Treatment: Extinguishing the Fire of Inflammation
Zhilei Wang, Guang Xu, Zhiyong Li, et al.
Journal of Inflammation Research (2022) Vol. Volume 15, pp. 409-422
Open Access | Times Cited: 19
Phytochemicals targeting lncRNAs: A novel direction for neuroprotection in neurological disorders
Hang Zhao, Lin Wang, Lijuan Zhang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 162, pp. 114692-114692
Closed Access | Times Cited: 11
A Systematic Review: Quercetin—Secondary Metabolite of the Flavonol Class, with Multiple Health Benefits and Low Bioavailability
Olimpia Daniela Frenț, Liana Ștefan, Claudia Mona Morgovan, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 12091-12091
Open Access | Times Cited: 3
Dietary Phytochemicals Targeting Nrf2 to Enhance the Radiosensitivity of Cancer
Pinghan Wang, Fangyi Long, Hong Lin, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-15
Open Access | Times Cited: 16
Analysis of the Flavonoidome Reveals the Different Health-Promoting Flavonoid Characteristics in Fruit
Chi Zhang, Yao Zhao, Han Tao, et al.
Antioxidants (2023) Vol. 12, Iss. 9, pp. 1665-1665
Open Access | Times Cited: 9
Therapeutic Properties of Flavonoids in Treatment of Cancer through Autophagic Modulation: A Systematic Review
Guilherme Vinício de Sousa Silva, Ana Luiza Vieira Ferreira Guimarães Lopes, Isis Carolina Viali, et al.
Chinese Journal of Integrative Medicine (2022) Vol. 29, Iss. 3, pp. 268-279
Open Access | Times Cited: 15
Tumor microenvironment responsive nano-herb and CRISPR delivery system for synergistic chemotherapy and immunotherapy
Yuanyuan Jia, Yuhui Yao, Lingyao Fan, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 2
Isoliquiritigenin as a modulator of the Nrf2 signaling pathway: potential therapeutic implications
Mangmang Qiu, Kang Ma, Junfeng Zhang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
Therapeutic effects of natural polyphenols on colorectal adenomas: Focus on preclinical studies (Review)
Fuqi Ma, Yuhua Lin, Zhenhua Ni, et al.
Oncology Reports (2023) Vol. 49, Iss. 6
Open Access | Times Cited: 6
Discovery of novel isoliquiritigenin analogue ISL-17 as a potential anti-gastric cancer agent
Fengchang Huang, Jin Wang, Yi Xu, et al.
Bioscience Reports (2020) Vol. 40, Iss. 6
Open Access | Times Cited: 16
Phytochemicals for the Prevention and Treatment of Renal Cell Carcinoma: Preclinical and Clinical Evidence and Molecular Mechanisms
Essa M. Bajalia, Farah B. Azzouz, Danielle A. Chism, et al.
Cancers (2022) Vol. 14, Iss. 13, pp. 3278-3278
Open Access | Times Cited: 9
Isoliquiritin can cause mitochondrial dysfunction and regulate Nrf2 to affect the development of mouse oocytes
Zhaoyang Sun, Anhui Jiao, Yuhan Zhao, et al.
Food and Chemical Toxicology (2024) Vol. 185, pp. 114445-114445
Closed Access | Times Cited: 1
Isoliquiritigenin attenuates neuroinflammation after subarachnoid hemorrhage through inhibition of NF‐κB‐mediated NLRP3 inflammasome activation
Wenfei Zhang, Xiang Tao, Chen Chen, et al.
Chemical Biology & Drug Design (2024) Vol. 103, Iss. 2
Closed Access | Times Cited: 1
Long-Circulating and Brain-Targeted Liposomes Loaded with Isoliquiritigenin: Formation, Characterization, Pharmacokinetics, and Distribution
Weitong Song, Lu Bai, Pingxiang Xu, et al.
Pharmaceutics (2024) Vol. 16, Iss. 8, pp. 975-975
Open Access | Times Cited: 1
Isoliquiritigenin Suppresses Breast Tumor Development by Enhancing Host Antitumor Immunity
Chun-Lu Yuan, Xiao-Lu Yang, Lei Sun, et al.
The American Journal of Chinese Medicine (2024), pp. 1-23
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top